
Vektor Medical
Vektor Medical, Inc. aims to revolutionize arrhythmia mapping with vMapâ¢, a next generation, non-invasive system.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | $16.0m | Series A | |
Total Funding | 000k |
Related Content
Vektor Medical, Inc. is pioneering advancements in the field of cardiac arrhythmia diagnostics with its next-generation, non-invasive mapping system. The company serves healthcare providers, particularly cardiologists, by offering a solution that leverages 12-lead ECG data to accurately locate potential sources of cardiac arrhythmias in all four chambers of the heart. This technology addresses a significant gap in the current standard of care, which often relies on antiarrhythmic drugs and anatomically based ablation therapy—both of which have limited success rates and can cause severe side effects.
Operating in the medical technology market, Vektor Medical's business model revolves around the development and commercialization of its proprietary mapping system. The company generates revenue through the sale of its diagnostic tools and potentially through service agreements for ongoing support and updates. By providing a more precise and non-invasive method for diagnosing arrhythmias, Vektor Medical aims to improve patient outcomes and reduce the risks associated with traditional treatment methods.
Founded by a team of engineers, scientists, doctors, and entrepreneurs, Vektor Medical is based in the United States and continues to innovate in the field of cardiac health.
Keywords: cardiac arrhythmia, non-invasive, 12-lead ECG, diagnostics, healthcare, cardiologists, mapping system, patient outcomes, medical technology, precision.